CSL Overview

  • Founded
  • 1916
Founded
  • Status
  • Public
  • Employees
  • 27,009
Employees
  • Stock Symbol
  • CSL
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $213.05
  • (As of Friday Closing)

CSL General Information

Description

CSL is the one of largest global biotech companies. Products are focused on two key areas - protein science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division. CSL has a strong research and development track record. The portfolio and pipeline include non-plasma products as the company broadens its biotech scope. Originally formed in Australia as a commonwealth-owned entity, CSL now earns half its revenue in North America and a quarter in Europe.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • 45 Poplar Road
  • Parkville, Victoria 3052
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CSL Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$213.05 $208.45 $139.54 - $234.97 $96.9B 455M 795K $4.63

CSL Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 94,335,059 94,335,059 72,183,002 67,598,162
Revenue 9,100,500 9,100,500 8,509,900 7,587,900
EBITDA 3,136,300 3,136,300 2,879,400 2,677,000
Net Income 2,102,500 2,102,500 1,918,700 1,728,900
Total Assets 15,464,600 15,464,600 12,314,400 10,774,500
Total Debt 5,992,800 5,992,800 4,662,800 4,386,300
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CSL Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CSL‘s full profile, request access.

Request a free trial

CSL Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CSL is the one of largest global biotech companies. Products are focused on two key areas - protein science therapies su
Biotechnology
Parkville, Australia
27,009 As of 2020
0000

00000 00

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000000000000
Beijing, China
0000 As of 0000
00000
0.000 0000-00-00
000000000000 00000

0000 000

ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CSL Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
China Biologic Products Holdings Corporation Beijing, China 0000 00000 000000000000 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000 000000000 Corporation Oxford, United Kingdom 000 00000 00000000 00000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
000000 00000 Corporation Mumbai, India 0000
You’re viewing 5 of 15 competitors. Get the full list »

CSL Executive Team (2)

Name Title Board Seat Contact Info
Joy Linton Chief Financial Officer
Paul Perreault Chief Executive Officer & Managing Director & Board Member
To view CSL’s complete executive team members history, request access »

CSL Board Members (9)

Name Representing Role Since
00000 0000000 CSL Board Member 000 0000
00000 00000 CSL Board Member, Chairman of the Audit and Risk Management Committee and Member of the Corporate Governance and Nomination Committee 000 0000
000000000 0'000000 CSL Board Member 000 0000
00000 0000000 Self Board Member 000 0000
0000 00000 CSL Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

CSL Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CSL Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CSL‘s full profile, request access.

Request a free trial

CSL Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000 28-Sep-2020 00000 00000 00 0000 Biotechnology
00000000 26-Sep-2019 00000 00000 00 0000 Drug Discovery
000000000 11-Sep-2017 000000000000000000 00000 Biotechnology 0000 000000000
00000 00000 0000 0 03-Aug-2017 000000000000000000 00000 Drug Discovery 0000 000000000
Seqirus 03-Aug-2015 Merger/Acquisition 00000 Other Pharmaceuticals and Biotechnology 0000 000000000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

CSL Subsidiaries (3)

Company Name Industry Location Founded
CSL Plasma Other Software 2019
0000000 Other Pharmaceuticals and Biotechnology Holly Springs, NC 0000
000000000 Biotechnology Tucson, AZ 0000
To view CSL’s complete subsidiaries history, request access »

CSL Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000 0000 09-Apr-2006 00000 00000 00 000 Completed
  • 3 buyers
To view CSL’s complete exits history, request access »